Study ID: Alliance A071102
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with Mgmt Promoter Hypermethylation
Bemidji Clinic, Fargo Region, Sioux Falls Region
Preston Steen, MD
Brain and Nervous System
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.